ABBIE ALADDIN: Open Payments
NPI 1487308433 · GIBSONIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 8 payments from 5 companies in 2025. Trend: 2023 $242 · 2024 $0 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $166 |
| ABBVIE INC. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Organon LLC | 1 | $20 |
| ViiV Healthcare Company | 1 | $16 |
Products named: MAVYRET, GARDASIL 9, NEXPLANON, APRETUDE.
Industry payments across PA — which companies pay providers there.
